Cancer Research Cancer Epigenetics  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 368-378, January 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Germain, L.
Right arrow Articles by Marceau, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Germain, L.
Right arrow Articles by Marceau, N.

Promotion of Growth and Differentiation of Rat Ductular Oval Cells in Primary Culture1

Lucie Germain2, Micheline Noël, Henriette Gourdeau and Normand Marceau3

Laval University Cancer Research Center, Hôtel-Dieu Hospital, and Department of Medicine, Laval University, Québec, G1R 2J6 Canada

Oval cells emerging in rat liver at the early period of 3-methyl-4-dimethylaminoazobenzene treatment constitute a mixed epithelial cell compartment with respect to {alpha}-fetoprotein (AFP) and cytokeratin differential expression, and include a subpopulation which exhibits a phenotype intermediate between ductular cells and hepatocytes (Germain et al., Cancer Res., 45: 673–681, 1985). In the present study we have examined the developmental potential of ductular oval cells in primary culture and after in vivo transfer. The use of monoclonal and polyclonal antibodies directed against cytokeratins of Mr 39,000 (CK39), 52,000 (CK52), and 55,000 (CK55) and vimentin, and also monoclonal antibodies against exposed surface components of oval cells (BDS7) and normal hepatocytes (HES6) allowed us to establish the ductular phenotype of the oval cells. A highly enriched preparation of oval cells was obtained by perfusion/digestion of the liver with collagenase, treatment of the cell suspension with trypsin and DNase, selective removal of hepatocytes by panning using the anti-HES6 antibody, and cell separation by isopyknic centrifugation in a Percoll gradient. The procedure yielded about 8 x 107 cells, of which 95% expressed CK39, CK52, and BDS7, 84% {gamma}-glutamyl transpeptidase, and 5% albumin and AFP. The primary response of cultured oval cells to various combinations of growth and differentiation promoting factors was evaluated with respect to their capacity to initiate DNA synthesis as measured by [3H]thymidine labeling from day 1 to 3, and/or to produce albumin and AFP and express tyrosine aminotransferase. Culture in the presence of either serum or clot blood extract resulted in a low proliferative activity with less than 5% of the nuclei being labeled. Over a 5-day period, fusion of a large portion of the oval cells led to multinucleated cells. When the cells were cultured in the presence of an elaborate combination of supplements [minimum essential medium containing 1 mM pyruvate, 0.2 mM aspartate, 0.2 mM serine, 1 mM tyrosine, 1 mM proline, 1 mM phenylalanine and supplemented with 20% clot blood extract, 10 ng/ml oxidized bile acids, 17 µM bilirubin, 10 ng/ml cholera toxin, 1 µM dexamethasone, 2.5 µg/ml insulin, 50 mM ß-mercaptoethanol, and 5 µg/ml transferrin (medium MX)], the labeling index increased to around 30% and the level of cell fusion greatly decreased. The addition of dimethyl sulfoxide further enhanced the initiation of DNA synthesis, while sodium butyrate acted as an inhibitor. Cell morphology varied depending on the combinations of factors used. Most of the oval cells still expressed the three cytokeratins, BDS7, {gamma}-glutamyl transpeptidase, and some vimentin after 5 days in culture. Culture in medium MX in the absence of sodium butyrate resulted in the emergence of a small subpopulation of BDS7 negative/{gamma}-glutamyl transpeptidase positive fusiform cells, which by day 5 constituted a distinct epithelial cell population that expressed CK39 and vimentin and which could be subcultured. The addition of dimethyl sulfoxide or sodium butyrate at day 1 in the presence of dexamethasone differentially modified the phenotype of the ductular oval cells cultured in growth factor-supplemented medium. Of major interest was the finding that the presence of sodium butyrate and dexamethasone led to a massive production of albumin over a 3-day period and a progressive induction of tyrosine aminotransferase activity. Fourteen days after the injection of freshly isolated oval cells into the fat pads of syngeneic rats, the cells were arranged as clusters similar to bile ductular structures. These findings indicate that oval cells isolated from 3-methyl-4-dimethylaminoazobenzene-treated rat liver which exhibit the phenotypic characteristics of bile ductular epithelial cells after in vivo transfer, produce albumin, cease AFP production, and express tyrosine aminotransferase activity in primary mass culture, properties of facultative hepatocytic precursors.

1 Supported by the National Cancer Institute of Canada. Presented in abstract form at the 77th annual meeting of the American Association for Cancer Research, May 7–10, 1986, Los Angeles, CA.

2 Recipient of a studentship from the Medical Research Council of Canada and Fonds de la Recherche en Santé du Québec.

3 To whom requests for reprints should be addressed, at Laval University Cancer Research Center, Hôtel-Dieu de Québec Hospital, 11 Côte du Palais, Québec, G1R 2J6, Canada.

Received 12/29/86. Revised 6/29/87. Revised 10/15/87. Accepted 10/19/87.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
C. K. Lau, Z. F. Yang, D. W. Ho, M. N. Ng, G. C.T. Yeoh, R. T.P. Poon, and S. T. Fan
An Akt/Hypoxia-Inducible Factor-1{alpha}/Platelet-Derived Growth Factor-BB Autocrine Loop Mediates Hypoxia-Induced Chemoresistance in Liver Cancer Cells and Tumorigenic Hepatic Progenitor Cells
Clin. Cancer Res., May 15, 2009; 15(10): 3462 - 3471.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Strick-Marchand, G. X. Masse, M. C. Weiss, and J. P. Di Santo
Lymphocytes Support Oval Cell-Dependent Liver Regeneration
J. Immunol., August 15, 2008; 181(4): 2764 - 2771.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Yang, H.-X. Yan, L. Chen, Q. Liu, Y.-Q. He, L.-X. Yu, S.-H. Zhang, D.-D. Huang, L. Tang, X.-N. Kong, et al.
Wnt/{beta}-Catenin Signaling Contributes to Activation of Normal and Tumorigenic Liver Progenitor Cells
Cancer Res., June 1, 2008; 68(11): 4287 - 4295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Mavier, N. Martin, D. Couchie, A.-M. Preaux, Y. Laperche, and E. S. Zafrani
Expression of Stromal Cell-Derived Factor-1 and of Its Receptor CXCR4 in Liver Regeneration from Oval Cells in Rat
Am. J. Pathol., December 1, 2004; 165(6): 1969 - 1977.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. L. Dumble, E. J. Croager, G. C.T. Yeoh, and E. A Quail
Generation and characterization of p53 null transformed hepatic progenitor cells: oval cells give rise to hepatocellular carcinoma
Carcinogenesis, March 1, 2002; 23(3): 435 - 445.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Holic, T. Suzuki, A. Corlu, D. Couchie, M. N. Chobert, C. Guguen-Guillouzo, and Y. Laperche
Differential Expression of the Rat {gamma}-Glutamyl Transpeptidase Gene Promoters along with Differentiation of Hepatoblasts into Biliary or Hepatocytic Lineage
Am. J. Pathol., August 1, 2000; 157(2): 537 - 548.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Kaplanski, C. J. Pauley, T. G. Griffiths, T. T. Kawabata, and B. J. Ledwith
Differentiation of Rat Oval Cells after Activation of Peroxisome Proliferator-activated Receptor {{alpha}}43
Cancer Res., February 1, 2000; 60(3): 580 - 587.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
G. J. Gordon, W. B. Coleman, D. C. Hixson, and J. W. Grisham
Liver Regeneration in Rats with Retrorsine-Induced Hepatocellular Injury Proceeds through a Novel Cellular Response
Am. J. Pathol., February 1, 2000; 156(2): 607 - 619.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
F. M. Spagnoli, L. Amicone, M. Tripodi, and M. C. Weiss
Identification of a Bipotential Precursor Cell in Hepatic Cell Lines Derived from Transgenic Mice Expressing Cyto-Met in the Liver
J. Cell Biol., November 16, 1998; 143(4): 1101 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M Michel, N Torok, M. Godbout, M Lussier, P Gaudreau, A Royal, and L Germain
Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage
J. Cell Sci., January 5, 1996; 109(5): 1017 - 1028.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.